Sequence information
Variant position: 166 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 419 The length of the canonical sequence.
Location on the sequence:
NALMPNWLHLPVGYHGRASS
V VVSGTPIRRPMGQMKPDDSK
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human NALMPNWLHLPVGYHGRASSV VVSGTPIRRPMGQMKPDDSK
Mouse NALLPNWLHLPVGYHGRASSI VVSGTPIRRPMGQMRPDNSK
Rat NALLPNWLHLPVGYHGRASSV VVSGTPIRRPMGQMRPDNSK
Bovine NALMPNWLHLPVGYHGRASSV VVSGTPIRRPLGQMRPDDSK
Caenorhabditis elegans NALMPNWKWLPVGYHGRASSI VVSGTDLKRPVGQTKAPDAE
Slime mold NALMPNWVHLPVGYHGRSSSI VVSGTPLKRPWGQTKSDEPD
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
2 – 419
Fumarylacetoacetase
Literature citations
Mutations of the fumarylacetoacetate hydrolase gene in four patients with tyrosinemia, type I.
Grompe M.; Al-Dhalimy M.;
Hum. Mutat. 2:85-93(1993)
Cited for: VARIANT TYRSN1 GLY-166;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.